<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>KETAVED- ketamine hydrochlorideÂ injection, solutionÂ </strong><br>Vedco Inc.<br></p></div>
<h1>
<span class="Bold">KETAVED<span class="Sup">Â®</span></span><br><span class="Bold">KETAMINE HYDROCHLORIDE INJECTION, USP</span><br><span class="Bold">ANADA 200-257, Approved by FDA </span>
</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_69ed5f19-8811-40a4-bda7-49df3f4605ec"></a><a name="section-1"></a><p></p>
<p class="First"><span class="Bold">Veterinary Injection for Intramuscular Use in Cats and Subhuman Primates Only</span></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_2d5dbf6e-476a-4111-9aeb-5f29577b1e6b"></a><a name="section-2"></a><p></p>
<h1>CAUTION</h1>
<p class="First">Federal law restricts this drug to use by or on the order of a licensed veterinarian.</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_8fd54505-cbc4-4abc-9fa7-7cb7ef7c1569"></a><a name="section-3"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">KetaVed (ketamine hydrochloride injection) is a rapid-acting, nonnarcotic, nonbarbiturate agent for anesthetic use in cats and for restraint in subhuman primates. It is chemically designated <span class="Italics">dl </span>2-(o-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride and is supplied as a slightly acid (pH 3.5 to 5.5) solution for intramuscular injection in a concentration containing the equivalent of 100 mg ketamine base per milliliter and contains not more than 0.1 mg/mL benzethonium chloride as a preservative.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_f7df04c5-c3ba-4667-ba83-da2f7e3ee0d5"></a><a name="section-4"></a><p></p>
<h1>ACTION</h1>
<p class="First">KetaVed is a rapid-acting agent whose pharmacological action is characterized by profound <span class="product-label-link" type="condition" conceptid="4242687" conceptname="No sensitivity to pain">analgesia</span>, normal pharyngeal-laryngeal reflexes, mild cardiac stimulation and <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">respiratory depression</span>. Skeletal muscle tone is variable and may be normal, enhanced or diminished. The anesthetic state produced does not fit into the conventional classification of stages of anesthesia, but instead KetaVed produces a state of <span class="product-label-link" type="condition" conceptid="372448" conceptname="Loss of consciousness">unconsciousness</span> which has been termed â€œdissociativeâ€? anesthesia in that it appears to selectively interrupt association pathways to the brain before producing somesthetic sensory blockade.</p>
<p>In contrast to other anesthetics, protective reflexes, such as <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">coughing</span> and swallowing are maintained under KetaVed anesthesia. The degree of muscle tone is dependent upon level of dose; therefore, variations in body temperature may occur. At low dosage levels there may be an increase in muscle tone and a concomitant slight increase in body temperature. However, at high dosage levels there is some diminution in muscle tone and a resultant decrease in body temperature, to the point where supplemental heat may be advisable.</p>
<p>In cats, there is usually some transient cardiovascular stimulation, increased <span class="product-label-link" type="condition" conceptid="4221102" conceptname="Cardiac output">cardiac output</span> with slight increase in mean systolic pressure with little or no change in total peripheral resistance. At higher doses, the <span class="product-label-link" type="condition" conceptid="4313591" conceptname="Respiratory rate">respiratory rate</span> is usually decreased.</p>
<p>The assurance of a patent airway is greatly enhanced by virtue of maintained pharyngeal-laryngeal reflexes. Although some <span class="product-label-link" type="condition" conceptid="4207204" conceptname="Excessive salivation">salivation</span> is occasionally noted, the persistence of the swallowing reflex aids in minimizing the hazards associated with <span class="product-label-link" type="condition" conceptid="4207204" conceptname="Excessive salivation">ptyalism</span>. <span class="product-label-link" type="condition" conceptid="4207204" conceptname="Excessive salivation">Salivation</span> may be effectively controlled with atropine sulfate in dosages of 0.04 mg/kg (0.02 mg/lb) in cats and 0.01 to 0.05 mg/kg (0.005 to 0.025 mg/lb) in subhuman primates.</p>
<p>Other reflexes, e.g., corneal, pedal, etc., are maintained during KetaVed anesthesia, and should not be used as criteria for judging depth of anesthesia. The eyes normally remain open with the <span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">pupils dilated</span>. It is suggested that a bland ophthalmic ointment be applied to the cornea if anesthesia is to be prolonged.</p>
<p>Following administration of recommended doses, cats become ataxic in about 5 minutes with anesthesia usually lasting from 30 to 45 minutes at higher doses. At the lower doses, complete recovery usually occurs in 4 to 5 hours but with higher doses recovery time is more prolonged and may be as long as 24 hours. </p>
<p>In studies involving 14 species of subhuman primates represented by at least 10 anesthetic episodes for each species, the median time to restraint ranged from 1.5 [Aotus trivirgatus (night monkey) and Cebus capucinus (white-throated capuchin)] to 5.3 minutes [Macaca nemestrina (pig-tailed macaque)]. The median duration of restraint ranged between 20 and 55 minutes in all but five of the species studied. Total time from injection to end of restraint ranged from 43 [Saimiri sciureus (squirrel monkey)] to 183 minutes [Macaca nemestrina (pig-tailed macaque)] after injection. Recovery is generally smooth and uneventful. The duration is dose related.</p>
<p>By single intramuscular injection, KetaVed usually has a wide margin of safety in cats and subhuman primates. In cats, cases of prolonged recovery and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> have been reported.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_db4549ca-d31c-4aca-9b91-0f634629d346"></a><a name="section-5"></a><p></p>
<h1>INDICATIONS</h1>
<p class="First">KetaVed may be used in cats for restraint or as the sole anesthetic agent for diagnostic or minor, brief, surgical procedures that do not require skeletal <span class="product-label-link" type="condition" conceptid="4002033" conceptname="Muscle relaxation">muscle relaxation</span>. It may be used in subhuman primates for restraint.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_77c7027d-82fd-4597-9795-ec3a4f17d49d"></a><a name="section-6"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">KetaVed is contraindicated in cats and subhuman primates suffering from renal or <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">hepatic insufficiency</span>.</p>
<p>KetaVed is detoxified by the liver and excreted by the kidneys; therefore, any preexistent hepatic or renal pathology or impairment of function can be expected to result in prolonged anesthesia; related fatalities have been reported.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_9777e183-b377-4640-bf95-3e7f47b2cf88"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First">In cats, doses in excess of 50 mg/kg during any single procedure should not be used. The maximum recommended dose in subhuman primates is 40 mg/kg.</p>
<p>To reduce the incidence of emergence reactions, animals should not be stimulated by sound or handling during the recovery period. However, this does not preclude the monitoring of vital signs. </p>
<p><span class="product-label-link" type="condition" conceptid="321689" conceptname="Apnea">Apnea</span>, <span class="product-label-link" type="condition" conceptid="317109" conceptname="Respiratory arrest">respiratory arrest</span>, <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">cardiac arrest</span> and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> have occasionally been reported with ketamine used alone, and more frequently when used in conjunction with sedatives or other anesthetics. Close monitoring of patients is strongly advised during induction, maintenance and recovery from anesthesia.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_44ab2a5d-62af-4dc3-b82e-ac8afe831e3e"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">Respiratory depression</span> may occur following administration of high doses of KetaVed. If at any time respiration becomes excessively depressed and the animal becomes cyanotic, resuscitative measures should be instituted promptly. Adequate pulmonary ventilation using either oxygen or room air is recommended as a resuscitative measure.</p>
<p>Adverse reactions reported have included <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span>, <span class="product-label-link" type="condition" conceptid="4207204" conceptname="Excessive salivation">salivation</span>, vocalization, erratic recovery and prolonged recovery, spastic jerking movements, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>, muscular <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremors</span>, <span class="product-label-link" type="condition" conceptid="4208994" conceptname="Increased muscle tone">hypertonicity</span>, <span class="product-label-link" type="condition" conceptid="4313849" conceptname="Opisthotonus">opisthotonos</span>, <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span> and <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">cardiac arrest</span>. In the cat, myoclonic jerking and/or mild <span class="product-label-link" type="condition" conceptid="4198075" conceptname="Tonic seizure">tonic convulsions</span> can be controlled by ultrashort-acting barbiturates which should be given to effect. <span class="Underline">The barbiturates should be administered intravenously at a dose level of one-sixth to one-fourth the usual dose for the product being used.</span> Acepromazine may also be used. However, recent information indicates that some phenothiazine derivatives may potentiate the toxic effects of organic phosphate compounds such as found in flea collars and certain anthelmintics. A study has indicated that ketamine hydrochloride alone does not potentiate the toxic effects of organic phosphate compounds.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_10c4a8a3-044e-48df-83aa-5b1033b0e192"></a><a name="section-9"></a><p></p>
<h1>ADMINISTRATION AND DOSAGE</h1>
<p class="First">KetaVed is well tolerated by cats and subhuman primates when administered by intramuscular injection.</p>
<p>Fasting prior to induction of anesthesia or restraint with KetaVed is not essential; however, when preparing for elective surgery, it is advisable to withhold food for at least six hours prior to administration of KetaVed.</p>
<p>Anesthesia may be of shorter duration in immature cats. Restraint in subhuman primate neonates (less than 24 hours of age) is difficult to achieve.</p>
<p>As with other anesthetic agents, the individual response to KetaVed is somewhat varied depending upon the dose, general condition and age of the subject so that dosage recommendations cannot be absolutely fixed.</p>
<p><span class="Bold">Dosage â€“</span></p>
<p><span class="Bold">Cats:</span> A dose of 11 mg/kg (5 mg/lb) is recommended to produce restraint. Dosages from 22 to 33 mg/kg (10 to 15 mg/lb) produce anesthesia that is suitable for diagnostic or minor surgical procedures that do not require skeletal <span class="product-label-link" type="condition" conceptid="4002033" conceptname="Muscle relaxation">muscle relaxation</span>.</p>
<p><span class="Bold">Subhuman Primates:</span> The recommended restraint dosages of KetaVed for the following species are: <span class="Italics">Cercocebus torquatus</span> (white-collared mangabey), <span class="Italics">Papio cynocephalus</span> (yellow baboon), <span class="Italics">Pantroglodytes verus</span> (chimpanzee), <span class="Italics">Papio anubis</span> (olive baboon), <span class="Italics">Pongo pygmaeus</span> (orangutan), <span class="Italics">Macaca nemestrina</span> (pig-tailed macaque) 5 to 7.5 mg/kg; <span class="Italics">Presbytis entellus</span> (entellus langur) 3 to 5 mg/kg; <span class="Italics">Gorilla gorilla gorilla</span> (gorilla) 7 to 10 mg/kg; <span class="Italics">Aotus trivirgatus</span> (night monkey) 10 to 12 mg/kg; <span class="Italics">Macaca mulatta</span> (rhesus monkey) 5 to 10 mg/kg; <span class="Italics">Cebus capucinus</span> (white-throated capuchin) 13 to 15 mg/kg; and <span class="Italics">Macaca fascicularis</span> (crab-eating macaque), <span class="Italics">Macaca radiata</span> (bonnet macaque) and <span class="Italics">Saimiri sciureus</span> (squirrel monkey) 12 to 15 mg/kg.</p>
<p>A single intramuscular injection produces restraint suitable for TB testing, radiography, physical examination or blood collection.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_e8ef6044-9263-4de1-bcef-4d5d7faec2e4"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">KetaVed is supplied as the hydrochloride in concentrations equivalent to ketamine base. </p>
<p>Each 10 mL multi-dose vial contains 100 mg/mL.<br>NDC 50989-996-06 â€“ 10 mL â€“ multi-dose vial.</p>
<p><span class="Bold">Store at 20Â° to 25Â°C (68Â° to 77Â°F). [See USP Controlled Room Temperature.]</span></p>
<p><span class="Bold">Protect from light.</span></p>
</div>
<div class="Section" data-sectionCode="34092-7">
<a name="i4i_clinical_studies_id_940c004a-f9a6-4781-bb11-32903b017336"></a><a name="section-11"></a><p></p>
<h1>CLINICAL STUDIES</h1>
<p class="First">KetaVed has been clinically studied in subhuman primates in addition to those species listed under Administration and Dosage. Dosages for restraint in these additional species, based on limited clinical data, are: <span class="Italics">Cercopithecus aethiops</span> (grivet), <span class="Italics">Papio papio</span> (guinea baboon) 10 to 12 mg/kg; <span class="Italics">Erythrocebus patas patas</span> (patas monkey) 3 to 5 mg/kg; <span class="Italics">Hylobates lar</span> (white-handed gibbon) 5 to 10 mg/kg; <span class="Italics">Lemur catta</span> (ringtailed lemur) 7.5 to 10 mg/kg; <span class="Italics">Macaca fuscata</span> (Japanese macaque) 5 mg/kg; <span class="Italics">Macaca speciosa</span> (stumptailed macaque) and <span class="Italics">Miopithecus talapoin</span> (mangrove monkey) 5 to 7.5 mg/kg; and <span class="Italics">Symphalangus syndactylus</span> (siamangs) 5 to 7 mg/kg.</p>
<p><br>Taxonomy from â€œA Handbook of Living Primatesâ€? by Napier and Napier, Academic Press, New York, N.Y.<br><br></p>
<p>Dist. by Vedco Inc.<br>St. Joseph, MO 64507</p>
<p>Manufactured by:<br><span class="Bold">Mylan Institutional<br></span>Galway, Ireland</p>
<p>Revised: May 2012<br>0630L101</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_08d13c36-1fc6-4b06-9905-c72860e5dc7e"></a><a name="section-12"></a><p></p>
<h1>PACKAGE/LABEL PRINCIPAL DISPLAY PANEL</h1>
<div class="Figure">
<a name="id12981836"></a><img alt="KetaVed Hydrochloride Injection 100 mg/mL Carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=57ec7d99-c36d-444e-8a2c-78a3b5798163&amp;name=e67805ba-1154-461f-8573-642c74e10aef-01.jpg">
</div>
<div class="Figure">
<a name="id12981840"></a><img alt="KetaVed Hydrochloride Injection 100 mg/mL Vial" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=57ec7d99-c36d-444e-8a2c-78a3b5798163&amp;name=e67805ba-1154-461f-8573-642c74e10aef-02.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>KETAVEDÂ 		
					</strong><br><span class="contentTableReg">ketamine hydrochloride injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">PRESCRIPTION ANIMAL DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:50989-996</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAMUSCULAR</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">CIIIÂ Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>KETAMINE HYDROCHLORIDE</strong> (KETAMINE) </td>
<td class="formItem">KETAMINE</td>
<td class="formItem">100Â mg Â inÂ 1Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BENZETHONIUM CHLORIDE</strong></td>
<td class="formItem">0.1Â mg Â inÂ 1Â mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:50989-996-06</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">10 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANADA</td>
<td class="formItem">ANADA200257</td>
<td class="formItem">05/31/2013</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Vedco Inc.
							(021634266)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 1/2013<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>e67805ba-1154-461f-8573-642c74e10aef</div>
<div>Set id: 57ec7d99-c36d-444e-8a2c-78a3b5798163</div>
<div>Version: 2</div>
<div>Effective Time: 20130104</div>
</div>
</div>Â <div class="DistributorName">Vedco Inc.</div></p>
</body></html>
